Seminars in Ophthalmology
Overview
Seminars in Ophthalmology is a peer-reviewed journal that provides a comprehensive platform for ophthalmologists and researchers to explore the latest advancements, techniques, and clinical practices in the field of ophthalmology. With a focus on promoting evidence-based medicine, this journal publishes high-quality articles, reviews, and case studies, covering a wide range of topics including ocular diseases, surgical procedures, diagnostic tools, and emerging therapies. It serves as an essential resource for ophthalmologists, residents, and allied healthcare professionals seeking to enhance
Details
Details
Abbr.
Semin Ophthalmol
Publisher
Informa Healthcare
Start
1986
End
Continuing
Frequency
Eight no. a year, 2018-
p-ISSN
0882-0538
e-ISSN
1744-5205
Country
United Kingdom
Language
English
Specialty
Ophthalmology
Metrics
Metrics
h-index / Ranks: 6131
60
SJR / Ranks: 6106
720
CiteScore / Ranks: 8993
2.80
JIF / Ranks: 5746
1.7
Recent Articles
1.
Sun Y, Zhang W, Hu B, Sun B, Zhang T, Yu S, et al.
Semin Ophthalmol
. 2025 Mar;
:1-7.
PMID: 40079155
Purpose: To evaluate and contrast the effectiveness and safety of two conbercept treatment protocols-a three-dose treat-and-extend (3+T&E) regimen and a three-dose pro re nata (3+PRN) regimen-in Chinese patients diagnosed with...
2.
3.
Kilictas A, Ozer F
Semin Ophthalmol
. 2025 Mar;
:1-13.
PMID: 40022537
Aim: To carry out an exhaustive bibliometric analysis of the existing literature on endoscopic dacryocystorhinostomy (DCR), with a view to comparing this with the trend in external DCR. Methods: A...
4.
Primary Enucleation for Intraocular Unilateral Retinoblastoma Can Save Life in Lower-Income Settings
Arazi M, Kfir J, Ahmad A, Foster A, Baum A, Stacey A, et al.
Semin Ophthalmol
. 2025 Feb;
:1-5.
PMID: 40009000
Objective: To investigate the outcomes of primary enucleation and adjuvant systemic chemotherapy, when deemed appropriate, on a cohort of children with unilateral intraocular Rb (AJCC 8th edition, cT2 and cT3)...
5.
Gowtham L, Sharma S, Bagga B
Semin Ophthalmol
. 2025 Feb;
:1-8.
PMID: 39998975
Purpose: The US Food and Drug Administration (USFDA) granted the miltefosine orphan drug designation in 2016 for treating keratitis. This study evaluates miltefosine's efficacy against clinical isolates of from patients...
6.
Incidence and Management of Retinopathy and Uveitis in Patients Receiving BRAF/MEK Inhibitor Therapy
Nakajima I, Yoshino K, Tsuji H
Semin Ophthalmol
. 2025 Feb;
:1-7.
PMID: 39991926
Purpose: To assess the clinical features of ocular adverse events in patients receiving BRAF/MEK inhibitor therapy. Methods: In this retrospective study, 65 patients were treated with BRAF/MEK inhibitors (dabrafenib/trametinib or...
7.
Ziafati M, Mirshahi R, Cicinelli M, Nazari R
Semin Ophthalmol
. 2025 Feb;
:1-13.
PMID: 39989218
Purpose: Persistent corneal epithelial defects (PCEDs) following pars plana vitrectomy (PPV) represent a significant clinical challenge, potentially leading to corneal scarring, vision loss, and other severe complications. This review aims...
8.
Lu T, Li Z, Manisundaram K, Kim S, Ning J, Esmaeli B
Semin Ophthalmol
. 2025 Feb;
:1-8.
PMID: 39982122
Background: Conjunctival melanoma (CM) is a rare and potentially aggressive malignancy of the ocular surface with high rates of local recurrence and metastasis. The objective of this report was to...
9.
10.
Ma L, Jiang X, Yang X, Wang M, Hou Z, Zhang J, et al.
Semin Ophthalmol
. 2025 Feb;
:1-7.
PMID: 39968895
Purpose: To develop CT-based machine learning radiomics models used for the diagnosis of dysthyroid optic neuropathy (DON). Materials And Methods: This is a retrospective study included 57 patients (114 orbits)...